Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mavacamten Dose Up-Titration in Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
NCT07807384Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Sep 2026
- Primary completion
- Sep 2026
01
Overview
A Phase 4 trial of mavacamten in hypertrophic cardiomyopathy (HCM), sponsored by The Second Affiliated Hospital of Nanchang University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
mavacamten
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT07807384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07807384.